Pharmafile Logo
Pharmafocus logo
Advanced Search
biogen_austria_238

Biogen gets CHMP thumbs up

May 27, 2014
Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …

News

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

News
janssen image

Janssen abandons Simponi application

May 23, 2014
Sales and Marketing Europe, Janssen, RA, Simponi, rheumatoid arthritis

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

News
Merck Serono image

Merck Serono rapped over hospitality

May 23, 2014
Medical Communications, Sales and Marketing ABPI, Merck KGaA, Merck Serono, PMCPA

The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …

News
aisha_pan

PAN appoints two and promotes three

May 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pan, doshi, fleming, gibbs, regan, valentine

Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …

Appointment
Roche image

Authorities visit Roche China offices

May 23, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic

A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …

News
Novartis image

Novartis pays $200m for eye technology

May 22, 2014
Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

News
screen_shot_2014-05-22_at_09

PM Society announces new co-chairs

May 22, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PRIME, farrow, jones, o'brien, pm society

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …

Appointment

ABPI hires new head of Commercial

May 22, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Watson

The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …

Appointment

‘Stop Alzheimer’s testing on animals’

May 22, 2014
Research and Development, Sales and Marketing AZ, Alzheimer's, Pfizer, humane, langley

Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …

News
Sepha Team Pharmafile

Sepha Encouraged by market response to new products launched at Interpack 2014!

May 21, 2014

News
Press release
Denny Bros Open day Pharmafile

Denny Bros Pharmaceutical Open Day Highlights the Need for Clearer and More Accurate Labelling

May 21, 2014

News
Press release
bms_close_logo

BMS and AbbVie get FDA lift

May 21, 2014
Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

News
Sovaldi pack shot

Gilead price lambasted by US health insurers

May 21, 2014
Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi

Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …

News
GSK logo

GSK’s Arzerra fails in lymphoma

May 21, 2014
Research and Development, Sales and Marketing Arzerra, GSK, Genmab, non-Hodgkin lymphoma

News
babs_joly

Rebranding and personnel news for Discovery London

May 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing holy, london discovery, medics, publicis

Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …

Appointment

GAVI vaccine group call for $7.5 billion funding

May 20, 2014
Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine

The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …

News

Medicus International rebrands as Discovery London

May 20, 2014
Medical Communications, Sales and Marketing Medicus International, Publicis Healthcare

Publicis Healthcare-owned medical communications group Medicus International has rebranded to Discovery London, thereby officially joining the Discovery worldwide brand. Discovery …

News
Janssen logo

Europe approves Janssen’s hep C drug Olysio

May 20, 2014
Research and Development, Sales and Marketing Janssen, hepatitis C, sovaldi

Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …

News
Abbott logo

Abbott makes Latin America move

May 20, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging

Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …

News
The Gateway to Local Adoption Series

Latest content

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026